• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Prostatype Genomics

0.47 SEK

-0.21 %

Less than 1K followers

PROGEN

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Compare
-0.21 %
-33.05 %
-54.81 %
+56.67 %
-18.97 %
-60.34 %
-99.52 %
-99.93 %
-99.87 %

Prostatype Genomics operates in the medical technology sector. The company specializes in the development of medical genetic tests used for the identification, analysis and further follow-up of prostate cancer. In addition to its main business, related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic market. The head office is located in Nacka Strand.

Read more
Market cap
27.82M SEK
Turnover
67.17K SEK
Revenue
594K
EBIT %
-6,555.22 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
30/6
2026

General meeting '26

23/7
2026

Interim report Q2'26

11/2
2027

Annual report '26

Regulatory press release6/1/2026, 8:45 AM

Prostatype Genomics publicerar årsredovisning för 2025

Prostatype Genomics
Regulatory press release6/1/2026, 8:45 AM

Prostatype Genomics publishes Annual Report for 2025

Prostatype Genomics
Regulatory press release5/25/2026, 6:45 AM

Uppdatering från Prostatype Genomics gällande processen med Medicare för kostnadsersättning av Prostatype® i USA

Prostatype Genomics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/25/2026, 6:45 AM

Update from Prostatype Genomics Regarding the Medicare Reimbursement Process for Prostatype® in the United States

Prostatype Genomics
Regulatory press release5/19/2026, 8:00 PM

KALLELSE TILL ÅRSSTÄMMA I Prostatype Genomics AB (PUBL)

Prostatype Genomics
Regulatory press release5/19/2026, 8:00 PM

NOTICE OF ANNUAL GENERAL MEETING IN PROSTATYPE GENOMICS AB (PUBL)

Prostatype Genomics
Regulatory press release5/19/2026, 7:50 PM

Prostatype Genomics AB meddelar styrelsens avsikt att besluta om en företrädesemission av units om cirka 47,4 MSEK

Prostatype Genomics
Regulatory press release5/19/2026, 7:50 PM

Prostatype Genomics AB announces the Board of Directors’ intention to resolve on a rights issue of units of approximately SEK 47.4 million

Prostatype Genomics
Regulatory press release2/26/2026, 3:45 PM

Prostatype Genomics publicerar bokslutskommuniké för 2025

Prostatype Genomics
Regulatory press release2/26/2026, 3:45 PM

Prostatype Genomics publishes year-end report for 2025

Prostatype Genomics
Press release1/29/2026, 10:31 AM

Analyst Group: Analyst Group intervjuar Prostatype Genomics VD Fredrik Persson

Prostatype Genomics
Third party research1/21/2026, 9:42 AM

Prostatype Genomics: VA-studie ger hopp - Analysguiden

Prostatypes USA-studie har nyligen presenterats i en vetenskaplig tidskrift. Vi tolkar de statistiska beräkningarna som övervägande positiva och tror att studiens publikation kan påskynda ett besked från det företag som granskar ansökningen till Medicare...

Prostatype Genomics
Press release1/21/2026, 9:35 AM

Analysguiden: ANALYS Prostatype Genomics: VA-studie ger hopp

Prostatype Genomics
Regulatory press release1/12/2026, 7:55 AM

Lånefinansiering om 10 MSEK till Prostatype Genomics AB

Prostatype Genomics
Regulatory press release1/12/2026, 7:55 AM

Loan financing of SEK 10 million to Prostatype Genomics AB

Prostatype Genomics
Regulatory press release1/8/2026, 6:30 PM

Prostatype Genomics amerikanska valideringsstudie utförd av Veterans Affairs (VA) har publicerats

Prostatype Genomics
Regulatory press release1/8/2026, 6:30 PM

Prostatype Genomics U.S. Validation study by Veterans Affairs (VA) is published

Prostatype Genomics
Regulatory press release11/25/2025, 1:30 PM

Prostatype Genomics nyhetsbrev: Uppdatering om Medicare-ansökan och publicering av studieresultat i USA

Prostatype Genomics
Regulatory press release11/25/2025, 1:30 PM

Prostatype Genomics' Newsletter: Update on Medicare application and publication of U.S. study results

Prostatype Genomics
Press release11/19/2025, 7:06 AM

BioStock: Video från Prostatype Genomics presentation vid BioStock Life Science Summit 2025

Prostatype Genomics